Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
13.42
+0.28 (2.13%)
Aug 10, 2026, 3:01 PM EDT - Market open

Alpha Tau Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,212436218---
Market Cap Growth
357.97%99.67%----
Enterprise Value
1,150376.25171.12000
Last Close Price
13.424.953.103.013.189.82

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.190.160.180.140.040
Net Debt / EBITDA Ratio
1.341.481.382.023.242.41
Net Debt / FCF Ratio
-1.812.142.814.012.13
Quick Ratio
7.316.966.8711.5224.107.11
Current Ratio
7.797.457.4012.0724.557.41
Return on Equity (ROE)
-77.67%-61.00%-43.16%-30.67%-54.09%-84.27%
Return on Assets (ROA)
-43.19%-44.21%-37.24%-31.38%-39.61%-28.98%
Return on Invested Capital (ROIC)
-370.82%-254.70%-228.41%-320.42%--
Return on Capital Employed (ROCE)
-47.86%-48.98%-40.54%-33.02%-41.84%-31.09%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-21.80%-15.24%-0.79%-9.20%-56.74%-0.64%
Total Shareholder Return
-21.80%-15.24%-0.79%-9.20%-56.74%-0.64%
SEC Filings: 10-K · 10-Q